SCHEMBL5449128

SCHEMBL5449128

Cc1ccc2cc(C=O)c(=O)[nH]c2c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 7/20 0.47
KDM4E B2RXH2 7/20 0.47
ALDH1A1 P00352 6/20 0.47
HPGD P15428 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
TSHR P16473 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.42
GAA P10253 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
GRIA1 P42261 1/20 0.42
GRIA2 P42262 1/20 0.42
GRIA3 P42263 1/20 0.42
GRIA4 P48058 1/20 0.42
PKM P14618 1/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAPK1 P28482 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29951711 1.00 HSD17B10 (0.47) HSD17B10KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL4071083 0.80 DAO (0.61) HSD17B10KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL26671161 0.77 CYP2A6 (0.43) HSD17B10KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL4070484 0.76 HSD17B10 (0.52) HSD17B10KDM4EALDH1A1SMN1; SMN2GRIA1
SCHEMBL29951486 0.76 GRIA1 (0.44) HSD17B10KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL20798358 0.75 GRIA1 (0.38) HSD17B10KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL17603345 0.73 GRIA1 (0.42) HSD17B10KDM4EALDH1A1SMN1; SMN2GAA
SCHEMBL19448889 0.71 DAO (0.60) HSD17B10KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL23149455 0.71 GRIA1 (0.35) KDM4EALDH1A1TSHRGRIA1GRIA2
SCHEMBL20798344 0.71 GRIA1 (0.35) HSD17B10KDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof AGRIUS GROUP, LLC. 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof ABCG2, ATP5ME, ATP5MG HSD17B10 1580/4885KDM4E 2403/4885ALDH1A1 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.